These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28679419)

  • 21. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).
    Pres D; Tajstra M; Mitkowski P; Ciślak A; Bujak K; Kaźmierczak J; Sterliński M; Mizia-Stec K; Sierpiński R; Gąsior M; Szumowski Ł; Kalarus Z
    Kardiol Pol; 2021; 79(12):1343-1352. PubMed ID: 34897630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
    Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
    Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death.
    House CM; Nguyen D; Thomas AJ; Nelson WB; Zhu DW
    J Card Fail; 2016 Feb; 22(2):125-32. PubMed ID: 26522819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system.
    Johnson BK; Garberich RF; Henry TD; Katsiyiannis WT; Sengupta J; Kalra A; Hauser RG; Lardy ME; Newell MC
    Heart Rhythm; 2016 Feb; 13(2):538-46. PubMed ID: 26576706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.
    Zhang Y; Guallar E; Blasco-Colmenares E; Butcher B; Norgard S; Nauffal V; Marine JE; Eldadah Z; Dickfeld T; Ellenbogen KA; Tomaselli GF; Cheng A
    J Am Coll Cardiol; 2015 Aug; 66(5):524-31. PubMed ID: 26227190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of Risk of Ventricular Arrhythmias After Improvement in Left Ventricular Ejection Fraction During Follow-Up in Patients With Primary Prevention Implantable Cardioverter Defibrillators.
    Smer A; Saurav A; Azzouz MS; Salih M; Ayan M; Abuzaid A; Akinapelli A; Kanmanthareddy A; Rosenfeld LE; Merchant FM; Abuissa H
    Am J Cardiol; 2017 Jul; 120(2):279-286. PubMed ID: 28532779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
    Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006).
    Scott PA; Gorman S; Andrews NP; Roberts PR; Kalra PR
    Europace; 2008 Apr; 10(4):453-7. PubMed ID: 18319266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
    Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
    Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.
    Schaer BA; Osswald S; Di Valentino M; Soliman OI; Sticherling C; ten Cate FJ; Jordaens L; Theuns DA
    Eur J Heart Fail; 2010 Dec; 12(12):1325-32. PubMed ID: 20923856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.
    Frigerio M; Lunati M; Pasqualucci D; Vargiu S; Foti G; Pedretti S; Vittori C; Cattafi G; Magenta G; Campo C; Bisetti S; Mercuro G
    Int J Cardiol; 2014 Mar; 172(1):64-71. PubMed ID: 24456869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial.
    Garzillo CL; Hueb W; Gersh BJ; Lima EG; Rezende PC; Hueb AC; Vieira RD; Favarato D; Pereira AC; Soares PR; Serrano CV; Ramires JA; Kalil Filho R
    Eur Heart J; 2013 Nov; 34(43):3370-7. PubMed ID: 23828828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Impact of Cardiac Magnetic Resonance Imaging Versus Echocardiography-Guided Patient Selection for Primary Prevention Implantable Cardioverter Defibrillator Therapy.
    Rijnierse MT; van der Lingen AL; Weiland MT; de Haan S; Nijveldt R; Beek AM; van Rossum AC; Allaart CP
    Am J Cardiol; 2015 Aug; 116(3):406-12. PubMed ID: 26050137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.